Overview
People who currently have or have had lymphoma and other cancers are at greater risk for severe infections and serious complications from influenza (the flu) and pneumonia.
The U.S. Centers for Disease… read more
Overview
In a survey of 700 people living with lymphoma, approximately 90 percent had used complementary or alternative treatments. Complementary treatments are those used alongside standard medical treatments… read more
Overview
Bexxar is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with CD20-positive, relapsed or refractory, low-grade, follicular, or transformed non-Hodgkin's lymphoma… read more
Overview
Erwinaze is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute lymphoblastic leukemia (ALL) who have developed an allergy to E. coli-derived asparaginase.… read more